AzTrials
AzTrials

PainAcupressNCT05311449

The Effect of Post-Cesarean Section Acupressure on the Severity of Pain and First Mobilization Distance

A study testing Acupressure and Plasebo acupressure in people with Pain and Mobilization, run by Mersin University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial evaluates the effect of acupressure application on cesareans' pain and the number of steps in the first mobilization. This study hypothesizes that acupressure reduces pain and improves number of steps. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pain, Mobilization
What is being tested?
Acupressure and Plasebo acupressure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
64 participants
Where
1 siteTurkey (Türkiye)
Study dates
26 Jun 2022to 22 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Being conscious,
  • The mother tongue is Turkish,
  • To be oriented and cooperative,
  • be between 18-45 years old,
  • To voluntarily agree to participate in the study (signing the Informed Consent Form),
  • Repeated cesarean section,
Show all 17Show fewer
  • Cesarean section under spinal anesthesia,
  • Not having a risky pregnancy (preeclampsia, gestational diabetes etc.),
  • No health problems of the fetus,
  • To have given birth by cesarean section between 37-40 weeks,
  • To be in the second hour of the postpartum period,
  • Not receiving post-op patient-controlled analgesia,
  • Not to have smoked or used alcohol during pregnancy,
  • No complications in the mother and/or newborn after cesarean section,
  • No sensitivity in the area where acupressure will be applied,
  • Absence of any systemic or psychiatric diagnosis,
  • Absence of active COVID-19 infection.

Who cannot join

  • Lack of consciousness,
  • The mother tongue is not Turkish,
  • Not oriented and cooperative,
  • Not to be between the ages of 18-45,
  • Refusal to voluntarily participate in the study (those who did not sign the Informed Consent Form),
  • Normal birth or cesarean delivery under general anesthesia,
Show all 15Show fewer
  • Cesarean delivery due to the risk of deterioration of maternal or fetal health,
  • Not having had a risky pregnancy (preeclampsia, gestational diabetes, etc.),
  • Not giving birth outside 37-40 weeks and by cesarean section,
  • Not in the second hour of the postpartum period,
  • Receiving post-op patient-controlled analgesia,
  • To have used cigarettes and alcohol during pregnancy,
  • Sensitivity in the area where acupressure will be applied,
  • Presence of any systemic or psychiatric diagnosis,
  • Active COVID-19 infection.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Mersin University

    Mersin, Yenişehir, 33343

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Acupressure After Cesarean Section on Pain Intensity and First Mobilization Distance: A Double-Blind Randomized Controlled Study

This randomized controlled trial evaluates the effect of acupressure application on cesareans' pain and the number of steps in the first mobilization. This study hypothesizes that acupressure reduces pain and improves number of steps.

Read the detailed description

Methods: In the study, 64 cesareans will randomly assigned to acupressure and placebo acupressure groups. To the acupressure group (n = 32), an average of 15 minutes will be applied to the LI4 (liver), P6 (pericardium) and the Sanyinjia points on the splenic meridian (SP6) located on the inner side of the lower leg, four fingers above the ankle and behind the tibia. In the placebo acupressure group (n = 32), the points 1.5 cm away from the LI4, P6 and SP6 points (four points in total) will be applied for an average of 15 minutes. The primary outcome of the research is the effect of acupressure on the pain of cesareans. The secondary outcome of the study is to determine the effect of acupressure on the number of steps. The pain will be collected before and 1 minute, 2nd and 4th hour after acupressure and placebo acupressure administration. The number of steps will be collected 4th hour after acupressure and placebo acupressure administration.

Conditions
Pain, Mobilization
Being tested
Acupressure, Plasebo acupressure
Keywords
Post-cesarean, Acupressure, Pain, Step, Mobilization
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AcupressureOther

    Also called Acupress

    The experimental group will start with LI4 points, and continue with P6 and SP6 points. The application will be carried out by determining the priority order of the points with the draw. Attention will be paid to the intensity and duration of the pressure deemed appropriate. Since the individuals' responses will differ, the stiffness and pressure will be adjusted according to the individual's sensitivity not to cause tissue damage. Before starting the application, around the area to be pressed for 20-30 seconds will be gently rubbed with palm. With the gentle rubbing of the surrounding tissue, the tension and tissue sensitivity in warming, relaxing and preparatory will be reduced, and the tissue will be relieved. After, the point determined will be pressed manually for 2 minutes.

  • Plasebo acupressureOther

    Also called Placebo Acupress

    In the control group, the application will start with the points 1.5 cm around the LI4, P6 and SP6 points. The application process will continue in the same way with acupressure group and the pressure intensity will be less.

Study groups in NCT05311449
Study groupRoleWhat they receive
Acupressure Group (experimental)ExperimentalThe experimental group will be given acupressure.
Receives: Other: Acupressure
Placebo Acupressure Group (control)Placebo comparatorThe placebo group will be given placebo acupressure.
Receives: Other: Plasebo acupressure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain evaluated using the visual analog scale

    The total scale score is in the range of 0 cm (minimum) -10 cm (maximum). A score of 0 indicates no pain and a score of 10 indicates very severe pain.

    Measured: Change from before implementation and after 1 minute, 2nd and 4th hour after implementation

Secondary outcomes (1)
  1. The number of steps using step counter (TNV 3D Pedometer (Model: PM2000, Made in China)

    The number of steps in the first mobilization will be evaluated with a pedometer.

    Measured: Change 4th hour after acupressure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2022
  2. Study start26 Jun 2022
  3. Primary completion26 Jun 2022
  4. Study completion22 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective, parallel, two-arm, randomized controlled clinical trial, double blind
Masking
None (open label)
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05311449
Sponsor's protocol ID
Mersin Universit
Acronym
Acupress
Status last verified
Sep 2022
First submitted
27 Mar 2022
Last updated
27 Sep 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Chen Y, Xiang XY, Chin KHR, Gao J, Wu J, Lao L, Chen H. Acupressure for labor pain management: a systematic review and meta-analysis of randomized controlled trials. Acupunct Med. 2021 Aug;39(4):243-252. doi: 10.1177/0964528420946044. Epub 2020 Aug 18.

    PubMed 32811182
  • Smith CA, Collins CT, Levett KM, Armour M, Dahlen HG, Tan AL, Mesgarpour B. Acupuncture or acupressure for pain management during labour. Cochrane Database Syst Rev. 2020 Feb 7;2(2):CD009232. doi: 10.1002/14651858.CD009232.pub2.

    PubMed 32032444
  • Akgun M, Boz I. The effects of acupressure on post-cesarean pain and analgesic consumption: a randomized single-blinded placebo-controlled study. Int J Qual Health Care. 2020 Nov 16;32(9):609-617. doi: 10.1093/intqhc/mzaa107.

    PubMed 32877509

Questions about this trial

What is this clinical trial studying?

A study testing Acupressure and Plasebo acupressure in people with Pain and Mobilization, run by Mersin University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 17 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain evaluated using the visual analog scale (time frame: Change from before implementation and after 1 minute, 2nd and 4th hour after implementation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05311449, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in